According to the new MRFR report, such factors include increasing number of clinical trials by top market players, rising number of product launches, growing initiatives by private & public organizations to create awareness about angioplasty treatment options, rising prevalence of cardiac diseases, demand for minimally invasive procedures, and technological advances in balloons.
Angioplasty is a minimally invasive endovascular technique used to widen obstructed or narrowed veins or arteries, generally to treat arterial atherosclerosis. Scoring balloons, drug-eluting balloons, cutting balloons, and normal balloons are the different types of angioplasty balloons that have wide applications in peripheral artery disease and coronary artery disease. They are widely used in ambulatory surgical centres, cardiac catheterization laboratories, hospitals, and others.
The MRFR report gives an inclusive segmental analysis of the global angioplasty balloons market report based on end-user, application, and product type.
By product type, the global angioplasty balloons market is segmented into scoring balloons, drug eluting balloons, cutting balloons, and normal balloons. Of these, normal balloons will lead the market over the forecast period for its high preference rate and widespread use.
By end-user, the global angioplasty balloons market is segmented into ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and others. Of these, hospitals will have the lion’s share in the market over the forecast period.
The global angioplasty balloons market in the APAC region is predicted to grow at a fast pace over the forecast period. Manufacturers are making vigorous marketing activities to increase potential targets which in turn is adding to the global angioplasty balloons market growth in the region.